Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

F131 - Neonatal Dermatology: Case-based Discussions

Monday, February 19; 1:00 PM - 3:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • More accurately evaluate and diagnose and treat neonatal dermatoses
  • Differentiate between benign and transient neonatal dermatosis, from those more severe ones.


This dynamic case based discussion is divided in two parts. During the first part difficult/interesting cases are presented. In the second part a case-based discussion is proposed encouraging the audience to participate.


  • Abad, Eugenia, MD: no financial relationships exist with commercial interests.
  • Friedlander, Sheila Fallon, MD: Menlo Therapeutics – A(H); Pfizer Inc. – A(H);
  • Larralde, Margarita M., MD: Eli Lilly and Company – I(H); Galderma Argentina, S.A. – SP(Fees); Genzyme Corporation – SP(Fees); La Roche-Posay Laboratorie Pharmaceutique – SP(Fees); Novartis – I(H); Pierre Fabre Dermatologie – SP(Fees);
  • Luna, Paula Carolina, MD: AbbVie – Speaker/Faculty Education(H); Eli Lilly and Company – I(Fees); Genzyme Corporation – Speaker/Faculty Education(H); La Roche-Posay Laboratorie Pharmaceutique – Speaker/Faculty Education(H); Novartis – I(Fees), Speaker/Faculty Education(H); Pierre Fabre Dermatologie – SP(H); Sanofi – SP(H);
  • McCuaig, Catherine C., MD: no financial relationships exist with commercial interests.
Event Details
  • Date
    Monday, February 19
  • Time
    1:00 PM - 3:00 PM
  • Location
    Room 29D
  • CME Credits
  • Type
  • Paula Carolina Luna, MD
  • Margarita M. Larralde, MD
  • Catherine C. McCuaig, MD, FAAD
  • Eugenia Abad, MD
  • Sheila Fallon Friedlander, MD, FAAD